(Q34704542)

English

Indications for and utilization of ACE inhibitors in older individuals with diabetes. Findings from the National Health and Nutrition Examination Survey 1999 to 2002

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 August 2017

Indications for and utilization of ACE inhibitors in older individuals with diabetes. Findings from the National Health and Nutrition Examination Survey 1999 to 2002 (English)

1 reference

Europe PubMed Central

4 August 2017

author name string

Allison B Rosen

1

1 reference

Europe PubMed Central

4 August 2017

publication date

1 April 2006

1 reference

Europe PubMed Central

4 August 2017

Journal of General Internal Medicine

1 reference

Europe PubMed Central

4 August 2017

21

1 reference

Europe PubMed Central

4 August 2017

4

1 reference

Europe PubMed Central

4 August 2017

315-319

1 reference

Europe PubMed Central

4 August 2017

https://scigraph.springernature.com/pub.10.1111/j.1525-1497.2006.00351.x

0 references

Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in high-risk clinical and ethnic groups with diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1484715

7 July 2018

Cardiovascular disease in patients who have diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1484715

7 July 2018

Using ACE inhibitors appropriately.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1484715

7 July 2018

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1484715

7 July 2018

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1484715

7 July 2018

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1484715

7 July 2018

Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors? A meta-analysis of individual patient data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1484715

7 July 2018

Randomized placebo-controlled trial of perindopril in normotensive, normoalbuminuric patients with type 1 diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1484715

7 July 2018

An evidence-based review of ACE inhibitors in incipient diabetic nephropathy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1484715

7 July 2018

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1484715

7 July 2018

https://api.crossref.org/works/10.1111%2FJ.1525-1497.2006.00351.X

21 January 2018

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1484715

7 July 2018

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1484715

7 July 2018

Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1484715

7 July 2018

Diabetes trends in the U.S.: 1990-1998.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1497.2006.00351.X

21 January 2018

Diabetes-related morbidity and mortality in a national sample of U.S. elders.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1497.2006.00351.X

21 January 2018

Use of enalapril to attenuate decline in renal function in normotensive, normoalbuminuric patients with type 2 diabetes mellitus. A randomized, controlled trial.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1497.2006.00351.X

21 January 2018

Effective postponement of diabetic nephropathy with enalapril in normotensive type 2 diabetic patients with microalbuminuria.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1497.2006.00351.X

21 January 2018

Reduced cardiovascular morbidity and mortality in hypertensive diabetic patients on first-line therapy with an ACE inhibitor compared with a diuretic/beta-blocker-based treatment regimen: a subanalysis of the Captopril Prevention Project

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1497.2006.00351.X

21 January 2018

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1497.2006.00351.X

21 January 2018

Use of losartan in the treatment of hypertensive patients with a history of cough induced by angiotensin-converting enzyme inhibitors.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1497.2006.00351.X

21 January 2018

Candesartan cilexetil is not associated with cough in hypertensive patients with enalapril-induced cough. Multicentre Cough Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1497.2006.00351.X

21 January 2018

Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1497.2006.00351.X

21 January 2018

Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1497.2006.00351.X

21 January 2018

Hyperkalemia in Outpatients Using Angiotensin-Converting Enzyme Inhibitors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1497.2006.00351.X

21 January 2018

The continuing epidemics of obesity and diabetes in the United States

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1484715

26 October 2018

Cause of Stroke Recurrence Is Multifactorial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1497.2006.00351.X

21 January 2018

Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. European Microalbuminuria Captopril Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/16686805

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Screening and management of microalbuminuria in patients with diabetes mellitus: recommendations to the Scientific Advisory Board of the National Kidney Foundation from an ad hoc committee of the Council on Diabetes Mellitus of the National Kidney F

1 reference

https://pubmed.ncbi.nlm.nih.gov/16686805

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improving use of ACE inhibitors in diabetic nephropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/16686805

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria. The EUCLID Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/16686805

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure

1 reference

https://pubmed.ncbi.nlm.nih.gov/16686805

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Why patients with diabetes, hypertension and/or proteinuria are not on angiotensin converting enzyme inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/16686805

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Standards of medical care in diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/16686805

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The care of patients with diabetic nephropathy: audit, feedback, and improvement

1 reference

https://pubmed.ncbi.nlm.nih.gov/16686805

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/16686805

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The use of ACE inhibitors as renoprotective agents in Medicaid patients with diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/16686805

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/16686805

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1525-1497.2006.00351.X

1 reference

Europe PubMed Central

4 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

4 August 2017

1 reference

Europe PubMed Central

4 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34704542&oldid=1395773577"